Esketamine Nasal Spray Effective for Treatment-Resistant Depression
Adult patients with treatment-resistant depression showed a favorable improvement in symptoms after a course of esketamine twice-weekly for 28 days.
All articles by Caleb Rans
Walk-In Psychiatric Urgent Care Model Shows Promise for Underserved Patients
Medicaid recipients were more likely to access psychiatric care through a walk-in session than through a scheduled appointment.
Differences in Basic Self Exist Between Schizotypal Disorder and Autism Spectrum Disorders
Self-experience could be valuable when clinically differentiating between schizotypal disorder and autism spectrum disorder.
Infliximab May Benefit Patients With Bipolar Depression and Childhood Trauma History
Infliximab-treated individuals with a childhood history of physical abuse exhibited reductions in depressive symptom scores.
Rate of Nonprescribed Fentanyl in Positive Urine Drug Screens Increasing
Positivity rates for nonprescribed fentanyl in cocaine- and methamphetamine-positive urine samples increased significantly between 2013 and 2018.
Amphetamine, Methylphenidate ADHD Treatment Linked to Adolescent Psychosis
Among adolescents and young adults with ADHD receiving prescription stimulants, new-onset psychosis occurred in approximately 1 in 660 patients.
Cognitive Processing Therapy Shows Benefit for PTSD in Youth
Youth with abuse-related posttraumatic stress disorder experienced greater benefit from developmentally adapted cognitive processing therapy vs a wait-list condition with treatment advice.
Repetitive TMS Effective for Comorbid Major Depressive Disorder, Anxiety
In those with comorbid major depressive and anxiety disorders, 23.3% met criteria for remission.
Patient Outcome Expectancy Associated With Clinical Responses in Depression
Patient outcome expectancy during treatment was associated with improved clinical responses for both pharmacotherapy and cognitive behavioral therapy (CBT) in patients with major depressive disorder, according to results from a study published in the Journal of Affective Disorders. The researchers recruited 104 outpatients with major depressive disorder who were randomly assigned to receive antidepressant therapy…
Quetiapine Shows Positive Responses in Methamphetamine Abuse
Quetiapine in patients with comorbid methamphetamine and opioid abuse showed improvements in depressive symptoms, sleep quality, and some cognitive function.
Next post in Addiction
